相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid
Katie E. Barber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Bacteremic pneumonia caused by extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Appropriateness of empirical treatment matters
Wan-Ling Cheng et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006-2010
Barbara E. Jones et al.
CLINICAL INFECTIOUS DISEASES (2015)
Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide
Helio S. Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections
Jordan L. Liscio et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Roger L. Nation et al.
LANCET INFECTIOUS DISEASES (2015)
Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study
Ignacio Martin-Loeches et al.
LANCET RESPIRATORY MEDICINE (2015)
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients
Timothy R. Pasquale et al.
JOURNAL OF CHEMOTHERAPY (2015)
Reduction of Bacterial Resistance with Inhaled Antibiotics in the Intensive Care Unit
Lucy B. Palmer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Imipenem, Meropenem, or Doripenem To Treat Patients with Pseudomonas aeruginosa Ventilator-Associated Pneumonia
Charles-Edouard Luyt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Predictive Value of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab PCR Assay for MRSA Pneumonia
Benjamin Dangerfield et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival
G. Ralph Corey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Epidemiology and Predictors of Multidrug-Resistant Community-Acquired and Health Care-Associated Pneumonia
Alan E. Gross et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Effectiveness of tigecycline-based versus colistin-based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis
Yu-Chung Chuang et al.
BMC INFECTIOUS DISEASES (2014)
Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-Analysis
James D. Chalmers et al.
CLINICAL INFECTIOUS DISEASES (2014)
A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
Samir S. Awad et al.
CLINICAL INFECTIOUS DISEASES (2014)
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2014)
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
Dennis L. Stevens et al.
CLINICAL INFECTIOUS DISEASES (2014)
Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis
Hsih-Yeh Tsai et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
G. Kalin et al.
INFECTION (2014)
Rising Rates of Carbapenem-Resistant Enterobacteriaceae in Community Hospitals: A Mixed-Methods Review of Epidemiology and Microbiology Practices in a Network of Community Hospitals in the Southeastern United States
Joshua T. Thaden et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2014)
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
Michael Klompas et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2014)
De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial
Marc Leone et al.
INTENSIVE CARE MEDICINE (2014)
Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study
Jordi Valles et al.
INTENSIVE CARE MEDICINE (2014)
Association Between Vancomycin Minimum Inhibitory Concentration and Mortality Among Patients With Staphylococcus aureus Bloodstream Infections A Systematic Review and Meta-analysis
Andre C. Kalil et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Determining a clinical framework for use of cefepime and -lactam/-lactamase inhibitors in the treatment of infections caused by extended-spectrum--lactamase-producing Enterobacteriaceae
Hien M. Nguyen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Analysis of Phase 3 telavancin nosocomial pneumonia data excluding patients with severe renal impairment and acute renal failure
A. Torres et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
The accuracy of Gram stain of respiratory specimens in excluding Staphylococcus aureus in ventilator-associated pneumonia
Tamar Gottesman et al.
JOURNAL OF CRITICAL CARE (2014)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A. Roberts et al.
LANCET INFECTIOUS DISEASES (2014)
Survey of Health Care-Associated Infections
Andreas Voss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
National Trends in Patient Safety for Four Common Conditions, 2005-2011
Yun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii
Hee Kyoung Choi et al.
YONSEI MEDICAL JOURNAL (2014)
Bacteremia and Ventilator-Associated Pneumonia: A Marker for Contemporaneous Extra-Pulmonic Infection
Anastasia Kunac et al.
SURGICAL INFECTIONS (2014)
Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients
Aziz Ogutlu et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2014)
Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia
Saad Nseir et al.
CRITICAL CARE (2014)
National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module
Margaret A. Dudeck et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2013)
Pseudomonas aeruginosa Ventilator-associated Pneumonia Predictive Factors of Treatment Failure
Benjamin Planquette et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients
Laurence Armand-Lefevre et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated Pneumonia A Systematic Review and Meta-analysis
George Dimopoulos et al.
CHEST (2013)
Is a Strategy Based on Routine Endotracheal Cultures the Best Way to Prescribe Antibiotics in Ventilator-Associated Pneumonia?
Carlos M. Luna et al.
CHEST (2013)
Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria
Mario Tumbarello et al.
CHEST (2013)
Toward Improved Surveillance: The Impact of Ventilator-Associated Complications on Length of Stay and Antibiotic Use in Patients in Intensive Care Units
Yoshiro Hayashi et al.
CLINICAL INFECTIOUS DISEASES (2013)
Combination Therapy for Pseudomonas aeruginosa Bacteremia: Where Do We Stand?
Mical Paul et al.
CLINICAL INFECTIOUS DISEASES (2013)
Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort
Carmen Pena et al.
CLINICAL INFECTIOUS DISEASES (2013)
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Emanuele Durante-Mangoni et al.
CLINICAL INFECTIOUS DISEASES (2013)
A Clinical Trial Comparing Physician Prompting With an Unprompted Automated Electronic Checklist to Reduce Empirical Antibiotic Utilization
Curtis H. Weiss et al.
CRITICAL CARE MEDICINE (2013)
Optimal Doripenem Dosing Simulations in Critically Ill Nosocomial Pneumonia Patients With Obesity, Augmented Renal Clearance, and Decreased Bacterial Susceptibility
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2013)
Validation of Predictors of Adverse Outcomes in Hospital-Acquired Pneumonia in the ICU
Mariano Esperatti et al.
CRITICAL CARE MEDICINE (2013)
ICU-Acquired Pneumonia With or Without Etiologic Diagnosis: A Comparison of Outcomes
Valeria Giunta et al.
CRITICAL CARE MEDICINE (2013)
Early Antibiotic Discontinuation in Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative Bronchoscopy Cultures
Kirthana Raman et al.
CRITICAL CARE MEDICINE (2013)
Diagnosis of ventilator-associated pneumonia: controversies and working toward a gold standard
Philip E. Grgurich et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2013)
Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
H. Aydemir et al.
EPIDEMIOLOGY AND INFECTION (2013)
Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality
C. Pena et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii
M. H. Rigatto et al.
INFECTION (2013)
Quantifying the Impact of Extranasal Testing of Body Sites for Methicillin-Resistant Staphylococcus aureus Colonization at the Time of Hospital or Intensive Care Unit Admission
James A. McKinnell et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
Dawn M. Sievert et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Prevalence and Risk Factors for Acquisition of Carbapenem-Resistant Enterobacteriaceae in the Setting of Endemicity
Mahesh Swaminathan et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Is the Present Definition of Health Care-Associated Pneumonia the Best Way to Define Risk of Infection with Antibiotic-Resistant Pathogens?
Vanessa Yap et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2013)
Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients
Christina Routsi et al.
INTENSIVE CARE MEDICINE (2013)
Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors
Ignacio Martin-Loeches et al.
INTENSIVE CARE MEDICINE (2013)
Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: A meta-analysis of retrospective and prospective studies
Yangmin Hu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: A meta-analysis
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia
David A. J. McDougall et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
Wilhelmina G. Melsen et al.
LANCET INFECTIOUS DISEASES (2013)
Comparison of the Bacterial Etiology of Early-Onset and Late-Onset Ventilator-Associated Pneumonia in Subjects Enrolled in 2 Large Clinical Studies
Marcos I. Restrepo et al.
RESPIRATORY CARE (2013)
Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia
D. A. Wooten et al.
RESPIRATORY MEDICINE (2013)
Antimicrobial use, incidence, etiology and resistance patterns in bacteria causing ventilator-associated pneumonia in a clinical-surgical intensive care unit
Michel Rodrigues Moreira et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2013)
THE DE-ESCALATION CONCEPT AND ANTIBIOTIC DE-ESCALATION: A MISSED OPPORTUNITY?
Luis Fernando A. Camargo
SHOCK (2013)
Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study
Neha M. Doshi et al.
BMC ANESTHESIOLOGY (2013)
Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis
Andre C. Kalil et al.
BMJ OPEN (2013)
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Richard S. Hotchkiss et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia
Joseph M. Swanson et al.
ANTIBIOTICS-BASEL (2013)
Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline
Sujata M. Bhavnani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia
Laura Morata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Correlation between the Consumption of Meropenem or Doripenem and Meropenem Susceptibility of Pseudomonas aeruginosa in a University Hospital in Japan
Koji Miyawaki et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomes
Nihal Piskin et al.
BMC INFECTIOUS DISEASES (2012)
Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia
So-Youn Park et al.
BMC INFECTIOUS DISEASES (2012)
β-Lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: A structured review
Mahipal G. Sinnollareddy et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Questionable Superiority of Linezolid for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: Watch Where You Step
Timothy Lahey
CLINICAL INFECTIOUS DISEASES (2012)
What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
Diana F. Florescu et al.
CLINICAL INFECTIOUS DISEASES (2012)
Is the Gram Stain Useful in the Microbiologic Diagnosis of VAP? A Meta-analysis
John C. O'Horo et al.
CLINICAL INFECTIOUS DISEASES (2012)
Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis
Philipp Schuetz et al.
CLINICAL INFECTIOUS DISEASES (2012)
Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
Richard G. Wunderink et al.
CLINICAL INFECTIOUS DISEASES (2012)
Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia
M. Giannella et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Pranita D. Tamma et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: Monotherapy or combination therapy?
F. Simsek et al.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort
Marin H. Kollef et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
Recent Exposure to Antimicrobials and Carbapenem-Resistant Enterobacteriaceae: The Role of Antimicrobial Stewardship
Dror Marchaim et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: An important determinant of outcome
John G. Muscedere et al.
JOURNAL OF CRITICAL CARE (2012)
Ventilator-associated pneumonia due to meticillin-resistant Staphylococcus aureus: risk factors and outcome in a large general hospital
E. Bouza et al.
JOURNAL OF HOSPITAL INFECTION (2012)
Ventilator-associated pneumonia: Bacteremia and death after traumatic injury
Grant E. O'Keefe et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2012)
Meta-analysis of Randomized Controlled Trials of Vancomycin for the Treatment of Patients With Gram-Positive Infections: Focus on the Study Design
Konstantinos Z. Vardakas et al.
MAYO CLINIC PROCEEDINGS (2012)
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment
Gilles Capellier et al.
PLOS ONE (2012)
Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) as a Diagnostic Marker of Ventilator-Associated Pneumonia
Steven J. Palazzo et al.
RESPIRATORY CARE (2012)
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia
Marin H. Kollef et al.
CRITICAL CARE (2012)
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Philipp Schuetz et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial
Jong Wook Kim et al.
CRITICAL CARE (2012)
National Healthcare Safety Network (NHSN) report, data summary for 2009, device-associated module
Margaret A. Dudeck et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2011)
High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia
Doo Ryeon Chung et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens
Jason A. Roberts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia
Hitoshi Honda et al.
BMC INFECTIOUS DISEASES (2011)
Ventilator-Associated Tracheobronchitis in a Mixed Surgical and Medical ICU Population
John Dallas et al.
CHEST (2011)
Linezolid vs Glycopeptide Antibiotics for the Treatment of Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia A Meta-analysis of Randomized Controlled Trials
Allan J. Walkey et al.
CHEST (2011)
Telavancin versus Vancomycin for HospitalAcquired Pneumonia due to Gram-positive Pathogens
Ethan Rubinstein et al.
CLINICAL INFECTIOUS DISEASES (2011)
De-Escalation Therapy: Is It Valuable for the Management of Ventilator-Associated Pneumonia?
Michael S. Niederman et al.
CLINICS IN CHEST MEDICINE (2011)
Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial
Jens U. Jensen et al.
CRITICAL CARE MEDICINE (2011)
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
J. Rello et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae
Indran Balakrishnan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns
Sebastiaan J. van Hal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia
Carla J. Walraven et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
Ana C. Gales et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Vancomycin Susceptibility Trends and Prevalence of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in Clinical Methicillin-Resistant S. aureus Isolates
Adam M. Pitz et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
Natasha E. Holmes et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Diagnostic Accuracy of Clinical Pulmonary Infection Score for Ventilator-Associated Pneumonia: A Meta-analysis
Jun Shan et al.
RESPIRATORY CARE (2011)
Diagnostic Utility of Plasma Procalcitonin for Nosocomial Pneumonia in the Intensive Care Unit Setting
John Dallas et al.
RESPIRATORY CARE (2011)
Tracheal aspirate Gram stain has limited sensitivity and specificity for detecting Staphylococcus aureus
Sodienye Tetenta et al.
RESPIROLOGY (2011)
Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study
Alessandro Montedori et al.
TRIALS (2011)
Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study
Paula Ramirez et al.
CRITICAL CARE (2011)
Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia
Mi Kyong Joung et al.
CRITICAL CARE (2011)
Nosocomial Pneumonia in the Intensive Care Unit Acquired by Mechanically Ventilated versus Nonventilated Patients
Mariano Esperatti et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006
Heather J. Adam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
Mical Paul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Worldwide Experience with the Use of Doripenem against Extended-Spectrum-β-Lactamase-Producing and Ciprofloxacin-Resistant Enterobacteriaceae: Analysis of Six Phase 3 Clinical Studies
Kone Kaniga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia A Prospective Cohort Trial
Fabian Mueller et al.
CHEST (2010)
Mortality, Attributable Mortality, and Clinical Events as End Points for Clinical Trials of Ventilator-Associated Pneumonia and Hospital-Acquired Pneumonia
John G. Muscedere et al.
CLINICAL INFECTIOUS DISEASES (2010)
Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator-Associated Pneumonia: A Matched Case-Control Study
Diamantis P. Kofteridis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Ronald N. Jones
CLINICAL INFECTIOUS DISEASES (2010)
Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
I. P. Korbila et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Addition of rifampin to vancomycin for the treatment of pneumonias due to methicillin-resistant Staphylococcus aureus: Caveat emptor
Keith M. Ramsey et al.
CRITICAL CARE MEDICINE (2010)
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis
Andre C. Kalil et al.
CRITICAL CARE MEDICINE (2010)
Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment
Kiran V. Sarikonda et al.
CRITICAL CARE MEDICINE (2010)
Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia
Young Ju Jung et al.
CRITICAL CARE MEDICINE (2010)
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
Anand Kumar et al.
CRITICAL CARE MEDICINE (2010)
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis
Anand Kumar et al.
CRITICAL CARE MEDICINE (2010)
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
Antonio T. Freire et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case-control study
M. Montero et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Pneumonia associated with invasive and noninvasive ventilation: an analysis of the German nosocomial infection surveillance system database
Anke Kohlenberg et al.
INTENSIVE CARE MEDICINE (2010)
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
Pinyo Rattanaumpawan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
Lila Bouadma et al.
LANCET (2010)
Controversies in Ventilator-Associated Pneumonia
Alain Combes et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Empiric, Broad-Spectrum Antibiotic Therapy with an Aggressive De-Escalation Strategy Does Not Induce Gram-Negative Pathogen Resistance in Ventilator-Associated Pneumonia
Michael L. Hibbard et al.
SURGICAL INFECTIONS (2010)
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review
Marya D. Zilberberg et al.
BMC PULMONARY MEDICINE (2010)
The Importance of Pathogen Identification in the Success of Treatment of Hospital Acquired Pneumonias
Ebru Cakir Edis et al.
TURKISH THORACIC JOURNAL (2010)
Duration of antibiotic therapy for ventilator-associated pneumonia: Comparison of 7 and 10 days. A pilot study
M. Fekih Hassen et al.
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION (2009)
Early- and Late-Onset Pneumonia: Is This Still a Useful Classification?
Petra Gastmeier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa
Amy L. Pakyz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine US Medical Centers from 2002 to 2006
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report
Pierre Emmanuel Charles et al.
BMC INFECTIOUS DISEASES (2009)
Diagnostic Implications of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in BAL Fluid of Patients With Pulmonary Infiltrates in the ICU
Nitin J. Anand et al.
CHEST (2009)
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
CLINICAL INFECTIOUS DISEASES (2009)
Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures
B. Herer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Pharmacokinetic issues for antibiotics in the critically ill patient
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation
Christian Bopp et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2009)
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
D. Stolz et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia
F. Scaglione et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
Leonardo Lorente et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
A prospective study of the diagnostic utility of sputum Gram stain in pneumonia
Stavros Anevlavis et al.
JOURNAL OF INFECTION (2009)
Hospital-Acquired Pneumonia Developed in Non-Intensive Care Units
Ebru Cakir Edis et al.
RESPIRATION (2009)
Does De-Escalation of Antibiotic Therapy for Ventilator-Associated Pneumonia Affect the Likelihood of Recurrent Pneumonia or Morality in Critically III Surgical Patients?
Soumitra R. Eachempati et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2009)
Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis
Eduardo Ferat-Osorio et al.
CRITICAL CARE (2009)
Risk Factors and Evolution of Ventilator-Associated Pneumonia by Staphylococcus aureus Sensitive or Resistant to Oxacillin in Patients at the Intensive Care Unit of a Brazilian University Hospital
Michel R. Moreira et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2008)
Early Microbiological Response to Linezolid vs Vancomycin in Ventilator-Associated Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
Richard G. Wunderink et al.
CHEST (2008)
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
Nikolaos Markou et al.
CLINICAL THERAPEUTICS (2008)
Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit
Lucy B. Palmer et al.
CRITICAL CARE MEDICINE (2008)
Empiric antibiotic therapy for suspected ventilator-associated pneumonia: A systematic review and meta-analysis of randomized trials
Mary-Anne W. Aarts et al.
CRITICAL CARE MEDICINE (2008)
Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia
Daren K. Heyland et al.
CRITICAL CARE MEDICINE (2008)
Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study
Jean Chastre et al.
CRITICAL CARE MEDICINE (2008)
Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia:: a randomized, open-label, multicenter study
Alvaro Rea-Neto et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia
P. Ramirez et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices
Timothy H. Dellit et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals
Susan E. Coffin et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia
Charles-Edouard Luyt et al.
INTENSIVE CARE MEDICINE (2008)
Multicenter survey on hospital-acquired pneumonia and the clinical efficacy of first-line antibiotics in Japan
Akira Watanabe et al.
INTERNAL MEDICINE (2008)
Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis
Effie L. Kuti et al.
JOURNAL OF CRITICAL CARE (2008)
The safety of targeted antibiotic therapy for ventilator-associated pneumonia: A multicenter observational study
Ari R. Joffe et al.
JOURNAL OF CRITICAL CARE (2008)
Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa:: Prevalence, incidence, risk factors, and outcomes
Chris M. Parker et al.
JOURNAL OF CRITICAL CARE (2008)
Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
Alex P. Betrosian et al.
JOURNAL OF INFECTION (2008)
A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly
T. Maruyama et al.
RESPIRATORY MEDICINE (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Subthreshold quantitative bronchoalveolar lavage: Clinical and therapeutic implications
Ajai K. Malhotra et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2008)
Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling
Ari Robicsek et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin an dantomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006
Robert L. Holmes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock
Suresh Ramasubban et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2008)
Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study
Saad Nseir et al.
CRITICAL CARE (2008)
Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia
P. Depuydt et al.
INTENSIVE CARE MEDICINE (2008)
Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan
S. Kohno et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/ora cefuroxime axetil in patients with hospital-acquired pneumonia
G. Hoeffken et al.
INFECTION (2007)
Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion:: A retrospective, nonrandomized, open-label, historical chart review
Leonardo Lorente et al.
CLINICAL THERAPEUTICS (2007)
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S-aureus (MRSA) blood isolates from 2001-05
Gregory Steinkraus et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
Guilherme Henrique Campos Furtado et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate
Elpis Giantsou et al.
INTENSIVE CARE MEDICINE (2007)
Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa
Spyros D. Mentzelopoulos et al.
INTENSIVE CARE MEDICINE (2007)
Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients
Emmanuel Boselli et al.
INTENSIVE CARE MEDICINE (2007)
Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia
Kemal Agbaht et al.
CRITICAL CARE MEDICINE (2007)
Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum β-lactamase-producing organisms in an intensive care unit
Matteo Bassetti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia:: An observational, multicenter study comparing monotherapy with combination antibiotic therapy
Jose Garnacho-Montero et al.
CRITICAL CARE MEDICINE (2007)
Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia
David J. Weber et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia - A preliminary report
Grigory Horonenko et al.
CHEST (2007)
Treatment of ventilator-associated pneumonia with piperacillin-tazobactum and amikacin vs cefepime and levofloxacin: A randomized prospective study
S. M. Ahmed et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2007)
Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients
C. Pena et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia
Meghan N. Jeffres et al.
CLINICAL THERAPEUTICS (2007)
Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia
K. M. C. Verhamme et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
I. I. Siempos et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii
Alex P. Betrosian et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial
Samir G. Sakka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A randomized trial of diagnostic techniques for ventilator-associated pneumonia
Daren Heyland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit
S. V. Yakovlev et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit
Jean Chastre et al.
CLINICAL INFECTIOUS DISEASES (2006)
Quantitative cultures for diagnosing ventilator-associated pneumonia: A critique
Shigeki Fujitani et al.
CLINICAL INFECTIOUS DISEASES (2006)
Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia
James R. Beardsley et al.
CHEST (2006)
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia - a double blind prospective multicentre study
D. V. Schmitt et al.
INFECTION (2006)
Postoperative pneumonia after major lung resection
Olivier Schussler et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Validation of an algorithm based on direct examination of specimens in suspected ventilator-associated pneumonia
A Veinstein et al.
INTENSIVE CARE MEDICINE (2006)
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia
Morin H. Kollef et al.
CHEST (2006)
Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]
Pierre Damas et al.
CRITICAL CARE (2006)
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study
Francisco Alvarez-Lerma et al.
CRITICAL CARE (2006)
Appropriateness and delay to initiate therapy in ventilator-associated pneumonia
CM Luna et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Beta lactam antibiotic monotherapy versus beta lactamaminoglycoside antibiotic combination therapy for sepsis
M Paul et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
De-escalation in lower respiratory tract infections
Thiago Lisboa et al.
CURRENT OPINION IN PULMONARY MEDICINE (2006)
Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia
Maniari Joshi et al.
RESPIRATORY MEDICINE (2006)
In vitro activity of β-lactam antimicrobial agents in combination with aztreonam tested against metallo-β-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii
HS Sader et al.
JOURNAL OF CHEMOTHERAPY (2005)
Epidemiology and outcomes of health-care-associated pneumonia - Results from a large US database of culture-positive pneumonia
MH Kollef et al.
CHEST (2005)
Risk factors and prognostic factors in nosocomial pneumonia outside the intensive care units setting
B Barreiro-López et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2005)
Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria
E Giantsou et al.
INTENSIVE CARE MEDICINE (2005)
Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia
RM Determann et al.
INTENSIVE CARE MEDICINE (2005)
Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results
MH Kollef et al.
CHEST (2005)
Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia
CA DeRyke et al.
CHEST (2005)
Contribution of blinded, protected quantitative specimens to the diagnostic and therapeutic management of ventilator-associated pneumonia
C Brun-Buisson et al.
CHEST (2005)
Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia
D Panidis et al.
CHEST (2005)
Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control study
S Nseir et al.
CRITICAL CARE (2005)
Hospital-acquired pneumonia in critically ill patients: Factors associated with episodes due to imipenem-resistant organisms
O Leroy et al.
INFECTION (2005)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Levofloxacin for treatment of ventilator-associated pneumonia: A subgroup analysis from a randomized trial
AF Shorr et al.
CLINICAL INFECTIOUS DISEASES (2005)
Multicenter study of hospital-acquired pneumonia in non-ICU patients
N Sopena et al.
CHEST (2005)
Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study
JA Cepeda et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections
M Wilcox et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia
S Gibot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection
KA Davis et al.
CLINICAL INFECTIOUS DISEASES (2004)
Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections
ME Sobieszczyk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis
N Safdar et al.
LANCET INFECTIOUS DISEASES (2004)
Outcomes of ventilated COPD patients with nosocomial tracheobronchitis: A case-control study
S Nseir et al.
INFECTION (2004)
Antibiotic therapy for Klebsiella pneumoniae bacteremia:: Implications of production of extended-spectrum β-lactamases
DL Paterson et al.
CLINICAL INFECTIOUS DISEASES (2004)
De-escalation therapy in ventilator-associated pneumonia
J Rello et al.
CRITICAL CARE MEDICINE (2004)
A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia
S Micek et al.
CHEST (2004)
Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults - A randomized trial
J Chastre et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Ventilator-associated pneumonia in a multi-hospital system: Differences in microbiology by location
HM Babcock et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria
JP Ouderkirk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Diagnosing pneumonia during mechanical ventilation -: The clinical pulmonary infection score revisited
M Fartoukh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin:: A comparison with imipenem-susceptible VAP
J Garnacho-Montero et al.
CLINICAL INFECTIOUS DISEASES (2003)
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study
M West et al.
CLINICAL THERAPEUTICS (2003)
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: A multicenter, evaluator-blind, prospective, randomized study
G Zanetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia
O Leroy et al.
INTENSIVE CARE MEDICINE (2003)
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia
F Pea et al.
CLINICAL PHARMACOKINETICS (2003)
Nosocomial tracheobronchitis in mechanically ventilated patients: incidence. aetiology and outcome
S Nseir et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Nosocomial pneumonia -: The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU
G Höffken et al.
CHEST (2002)
Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens
O Leroy et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia
GC Wood et al.
CLINICAL INFECTIOUS DISEASES (2002)
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections
DL Stevens et al.
CLINICAL INFECTIOUS DISEASES (2002)
Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation
M Oppert et al.
RESUSCITATION (2002)
Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: Results of the Eole study
P Montravers et al.
CRITICAL CARE MEDICINE (2002)
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia
B Maskin et al.
CRITICAL CARE MEDICINE (2002)
Prognostic factors of nosocomial pneumonia in general wards: a prospective multivariate analysis in Japan
Y Takano et al.
RESPIRATORY MEDICINE (2002)
Alveolar and serum procalcitonin - Diagnostic and prognostic value in ventilator-associated pneumonia
F Duflo et al.
ANESTHESIOLOGY (2002)
Diagnostic investigation of ventilator-associated pneumonia using bronchoalveolar lavage:: comparative study with a postmortem lung biopsy
AB Balthazar et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2001)
Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections
SK Fridkin et al.
CLINICAL INFECTIOUS DISEASES (2001)
Diagnosis of nosocomial pneumonia in medical ward:: repeatability of the protected specimen brush
B Herer et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
DP Nicolau et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Experience with a clinical guideline for the treatment of ventilator-associated pneumonia
EH Ibrahim et al.
CRITICAL CARE MEDICINE (2001)
Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients:: a prospective randomized multicenter trial
F Alvarez-Lerma et al.
INTENSIVE CARE MEDICINE (2001)
Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia
FA Lerma
JOURNAL OF CHEMOTHERAPY (2001)
Treatment of severe nosocomial pneumonia:: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin
A Torres et al.
THORAX (2000)
Diagnostic accuracy of protected catheter sampling in ventilator-associated bacterial pneumonia
F Bregeon et al.
EUROPEAN RESPIRATORY JOURNAL (2000)
Incidence and susceptibility or pathogenic bacteria vary between intensive care units within a single hospital: Implications for empiric antibiotic strategies
N Namias et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2000)
Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia
JS Violán et al.
CRITICAL CARE MEDICINE (2000)
Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit - A proposed solution for indiscriminate antibiotic prescription
N Singh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia -: Evaluation of outcome
M Ruiz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome -: Incidence, prognosis, and risk factors
P Markowicz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Intermittent and continuous ceftazidime infusion for critically ill trauma patients
SD Hanes et al.
AMERICAN JOURNAL OF SURGERY (2000)
Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia -: A randomized trial
JY Fagon et al.
ANNALS OF INTERNAL MEDICINE (2000)
Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes
A Bouchon et al.
JOURNAL OF IMMUNOLOGY (2000)
Treatment of gram-positive nosocomial pneumonia - Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin
JY Fagon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting
EH Ibrahim et al.
CHEST (2000)
分享论文
